Cargando…

Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage

Immune function changes across the life stages; for example, senior adults exhibit a tendency towards a weaker cell-mediated immune response and a stronger inflammatory response than younger adults. This might be partly mediated by changes in oxylipin synthesis across the life course. Oxylipins are...

Descripción completa

Detalles Bibliográficos
Autores principales: von Gerichten, Johanna, West, Annette L., Irvine, Nicola A., Miles, Elizabeth A., Calder, Philip C., Lillycrop, Karen A., Burdge, Graham C., Fielding, Barbara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300345/
https://www.ncbi.nlm.nih.gov/pubmed/37388745
http://dx.doi.org/10.3389/fimmu.2023.1206733
_version_ 1785064567591665664
author von Gerichten, Johanna
West, Annette L.
Irvine, Nicola A.
Miles, Elizabeth A.
Calder, Philip C.
Lillycrop, Karen A.
Burdge, Graham C.
Fielding, Barbara A.
author_facet von Gerichten, Johanna
West, Annette L.
Irvine, Nicola A.
Miles, Elizabeth A.
Calder, Philip C.
Lillycrop, Karen A.
Burdge, Graham C.
Fielding, Barbara A.
author_sort von Gerichten, Johanna
collection PubMed
description Immune function changes across the life stages; for example, senior adults exhibit a tendency towards a weaker cell-mediated immune response and a stronger inflammatory response than younger adults. This might be partly mediated by changes in oxylipin synthesis across the life course. Oxylipins are oxidation products of polyunsaturated fatty acids (PUFAs) that modulate immune function and inflammation. A number of PUFAs are precursors to oxylipins, including the essential fatty acids (EFAs) linoleic acid (LA) and α-linolenic acid (ALA). LA and ALA are also substrates for synthesis of longer chain PUFAs. Studies with stable isotopes have shown that the relative amounts of LA and ALA can influence their partitioning by T lymphocytes between conversion to longer chain PUFAs and to oxylipins. It is not known whether the relative availability of EFA substrates influences the overall pattern of oxylipin secretion by human T cells or if this changes across the life stages. To address this, the oxylipin profile was determined in supernatants from resting and mitogen activated human CD3(+) T cell cultures incubated in medium containing an EFA ratio of either 5:1 or 8:1 (LA : ALA). Furthermore, oxylipin profiles in supernatants of T cells from three life stages, namely fetal (derived from umbilical cord blood), adults and seniors, treated with the 5:1 EFA ratio were determined. The extracellular oxylipin profiles were affected more by the EFA ratio than mitogen stimulation such that n-3 PUFA-derived oxylipin concentrations were higher with the 5:1 EFA ratio than the 8:1 ratio, possibly due to PUFA precursor competition for lipoxygenases. 47 oxylipin species were measured in all cell culture supernatants. Extracellular oxylipin concentrations were generally higher for fetal T cells than for T cells from adult and senior donors, although the composition of oxylipins was similar across the life stages. The contribution of oxylipins towards an immunological phenotype might be due to the capacity of T cells to synthesize oxylipins rather than the nature of the oxylipins produced.
format Online
Article
Text
id pubmed-10300345
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103003452023-06-29 Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage von Gerichten, Johanna West, Annette L. Irvine, Nicola A. Miles, Elizabeth A. Calder, Philip C. Lillycrop, Karen A. Burdge, Graham C. Fielding, Barbara A. Front Immunol Immunology Immune function changes across the life stages; for example, senior adults exhibit a tendency towards a weaker cell-mediated immune response and a stronger inflammatory response than younger adults. This might be partly mediated by changes in oxylipin synthesis across the life course. Oxylipins are oxidation products of polyunsaturated fatty acids (PUFAs) that modulate immune function and inflammation. A number of PUFAs are precursors to oxylipins, including the essential fatty acids (EFAs) linoleic acid (LA) and α-linolenic acid (ALA). LA and ALA are also substrates for synthesis of longer chain PUFAs. Studies with stable isotopes have shown that the relative amounts of LA and ALA can influence their partitioning by T lymphocytes between conversion to longer chain PUFAs and to oxylipins. It is not known whether the relative availability of EFA substrates influences the overall pattern of oxylipin secretion by human T cells or if this changes across the life stages. To address this, the oxylipin profile was determined in supernatants from resting and mitogen activated human CD3(+) T cell cultures incubated in medium containing an EFA ratio of either 5:1 or 8:1 (LA : ALA). Furthermore, oxylipin profiles in supernatants of T cells from three life stages, namely fetal (derived from umbilical cord blood), adults and seniors, treated with the 5:1 EFA ratio were determined. The extracellular oxylipin profiles were affected more by the EFA ratio than mitogen stimulation such that n-3 PUFA-derived oxylipin concentrations were higher with the 5:1 EFA ratio than the 8:1 ratio, possibly due to PUFA precursor competition for lipoxygenases. 47 oxylipin species were measured in all cell culture supernatants. Extracellular oxylipin concentrations were generally higher for fetal T cells than for T cells from adult and senior donors, although the composition of oxylipins was similar across the life stages. The contribution of oxylipins towards an immunological phenotype might be due to the capacity of T cells to synthesize oxylipins rather than the nature of the oxylipins produced. Frontiers Media S.A. 2023-06-14 /pmc/articles/PMC10300345/ /pubmed/37388745 http://dx.doi.org/10.3389/fimmu.2023.1206733 Text en Copyright © 2023 von Gerichten, West, Irvine, Miles, Calder, Lillycrop, Burdge and Fielding https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
von Gerichten, Johanna
West, Annette L.
Irvine, Nicola A.
Miles, Elizabeth A.
Calder, Philip C.
Lillycrop, Karen A.
Burdge, Graham C.
Fielding, Barbara A.
Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
title Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
title_full Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
title_fullStr Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
title_full_unstemmed Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
title_short Oxylipin secretion by human CD3(+) T lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
title_sort oxylipin secretion by human cd3(+) t lymphocytes in vitro is modified by the exogenous essential fatty acid ratio and life stage
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300345/
https://www.ncbi.nlm.nih.gov/pubmed/37388745
http://dx.doi.org/10.3389/fimmu.2023.1206733
work_keys_str_mv AT vongerichtenjohanna oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT westannettel oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT irvinenicolaa oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT mileselizabetha oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT calderphilipc oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT lillycropkarena oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT burdgegrahamc oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage
AT fieldingbarbaraa oxylipinsecretionbyhumancd3tlymphocytesinvitroismodifiedbytheexogenousessentialfattyacidratioandlifestage